drugset / Trial / NCT00871104

Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis

NCT00871104

Phase 4 Completed 50 enrolled Juan A. Arnaiz
RandomizedParallel-groupOpen-labelTreatment

Summary

The study evaluates the efficacy and safety of fosfomycin and imipenem for the treatment of methicillin-resistant staphyloccocus aureus infective endocarditis in comparison to vancomycin, the standard therapy.

Timeline

Start
2009-07
Primary completion
2014-07
Completion
2015-04-15

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fosfomycin Small molecule 2 g Intravenous
Subject IMIPENEM ANHYDROUS Small molecule 1 g Intravenous
Comparator Vancomycin Other / unclassified 30 mg/kg Intravenous